human clusterin quantikine elisa kit Search Results


94
R&D Systems clusterin clu
Label-free mass spectrometry data. List of statistically significant discovered proteins using LC-MS analysis. Proteins (in bold) were selected for further validation using ELISAs.
Clusterin Clu, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clusterin clu/product/R&D Systems
Average 94 stars, based on 1 article reviews
clusterin clu - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
R&D Systems human clusterin quantikine elisa kit
Median (IQR) levels of urinary biomarkers adjusted to urinary creatinine on days 1 to 7.
Human Clusterin Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human clusterin quantikine elisa kit/product/R&D Systems
Average 93 stars, based on 1 article reviews
human clusterin quantikine elisa kit - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Label-free mass spectrometry data. List of statistically significant discovered proteins using LC-MS analysis. Proteins (in bold) were selected for further validation using ELISAs.

Journal: BBA Clinical

Article Title: Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients

doi: 10.1016/j.bbacli.2017.05.003

Figure Lengend Snippet: Label-free mass spectrometry data. List of statistically significant discovered proteins using LC-MS analysis. Proteins (in bold) were selected for further validation using ELISAs.

Article Snippet: Four commercially available kits for these four proteins; angiogenin (ANG) [Abcam, UK - ab99970], clusterin (CLU) [R&D system, UK - DCLU00], C-C Motif Chemokine 18 (CCL18) [Abcam, UK - ab100620], and Complement C1q [Abcam, UK - ab170246] were used.

Techniques: Mass Spectrometry, Biomarker Discovery, Variant Assay

ELISA Data. Mean, SD, Area under the curve (AUC) and p -value for each of the new and standard proteins found in the two groups of patients compared.

Journal: BBA Clinical

Article Title: Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients

doi: 10.1016/j.bbacli.2017.05.003

Figure Lengend Snippet: ELISA Data. Mean, SD, Area under the curve (AUC) and p -value for each of the new and standard proteins found in the two groups of patients compared.

Article Snippet: Four commercially available kits for these four proteins; angiogenin (ANG) [Abcam, UK - ab99970], clusterin (CLU) [R&D system, UK - DCLU00], C-C Motif Chemokine 18 (CCL18) [Abcam, UK - ab100620], and Complement C1q [Abcam, UK - ab170246] were used.

Techniques: Enzyme-linked Immunosorbent Assay

Logistic regression analysis data. List of different protein combinations used to establish the best model that can be used as a predictive panel for response to induction therapy containing bortezomib regime.

Journal: BBA Clinical

Article Title: Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients

doi: 10.1016/j.bbacli.2017.05.003

Figure Lengend Snippet: Logistic regression analysis data. List of different protein combinations used to establish the best model that can be used as a predictive panel for response to induction therapy containing bortezomib regime.

Article Snippet: Four commercially available kits for these four proteins; angiogenin (ANG) [Abcam, UK - ab99970], clusterin (CLU) [R&D system, UK - DCLU00], C-C Motif Chemokine 18 (CCL18) [Abcam, UK - ab100620], and Complement C1q [Abcam, UK - ab170246] were used.

Techniques:

Median (IQR) levels of urinary biomarkers adjusted to urinary creatinine on days 1 to 7.

Journal: Medicine

Article Title: Serum and urinary biomarkers of vancomycin-induced acute kidney injury: A prospective, observational analysis

doi: 10.1097/MD.0000000000039202

Figure Lengend Snippet: Median (IQR) levels of urinary biomarkers adjusted to urinary creatinine on days 1 to 7.

Article Snippet: Enzyme-linked immunosorbent assay (ELISA) was performed in duplicate for measuring clusterin (Human Clusterin Quantikine ELISA Kit; R&D Systems, Minneapolis, MN), KIM-1 (Human TIM-1/KIM-1/HAVCR Quantikine ELISA Kit; R&D Systems), and NGAL (Human Lipocalin-2/NGAL Quantikine ELISA Kit; R&D Systems), using commercial kits following the manufacturers’ instructions.

Techniques:

Area under the receiver operating characteristic curves based on the maximum values of urinary biomarkers from days 1 to 7 for vancomycin-associated acute kidney injury prediction. (A) KIM-1, (B) NGAL, and (C) clusterin. All values were adjusted based on urinary creatinine levels. KIM-1 = kidney injury molecule 1, NGAL = neutrophil gelatinase-associated lipocalin.

Journal: Medicine

Article Title: Serum and urinary biomarkers of vancomycin-induced acute kidney injury: A prospective, observational analysis

doi: 10.1097/MD.0000000000039202

Figure Lengend Snippet: Area under the receiver operating characteristic curves based on the maximum values of urinary biomarkers from days 1 to 7 for vancomycin-associated acute kidney injury prediction. (A) KIM-1, (B) NGAL, and (C) clusterin. All values were adjusted based on urinary creatinine levels. KIM-1 = kidney injury molecule 1, NGAL = neutrophil gelatinase-associated lipocalin.

Article Snippet: Enzyme-linked immunosorbent assay (ELISA) was performed in duplicate for measuring clusterin (Human Clusterin Quantikine ELISA Kit; R&D Systems, Minneapolis, MN), KIM-1 (Human TIM-1/KIM-1/HAVCR Quantikine ELISA Kit; R&D Systems), and NGAL (Human Lipocalin-2/NGAL Quantikine ELISA Kit; R&D Systems), using commercial kits following the manufacturers’ instructions.

Techniques: